Lyme Borreliosis Prevention: A Vaccine is on the Way
Technical solution for a complicated separation problem in the downstream process
Lyme disease has spread dramatically in recent years. The disease is transmitted by ticks contaminated with bacteria of the genus Borrelia. No vaccine is currently available, but Valneva, a biotech company that develops innovative vaccines against infectious diseases, is working hard on a new vaccine against Lyme disease.
With the perfect technical solution for a complicated separation problem in the downstream process, ZETA made an important contribution to the production of the valuable active ingredient and thus played a significant role on the way to the early market launch of the urgently needed vaccine.
ZETA: Expertise in vaccine production
This project is one of many successful projects in the field of vaccine production in which ZETA has been able to support customers worldwide with its expertise and many years of experience in biopharmaceutical production.
Technical Article: A Vaccine for Lyme Borreliosis is on the Way!
